H.Amdt. 239House109th Congress (2005-2007)

An amendment to prohibit the use of funds from being made available to keep in effect an exemption for a clinical trial that concerns a life-threatening disease or condition and is not included in the registry of such trials. Amendment also seeks to prohibit the use of funds to approve certain applications.

What it does: Adds Sec. 7__. None of the funds made available in this Act may be used by the Secretary of Health and Human Services to keep in effect an exemption under section 505(i) of the Federal Food, Drug, and Cosmetic Act for a clinical trial that concerns a serious or life-threatening disease or condition and is not included in the registry of such trials under section 402(j) of the Public Health Service Act on page 83, line 19
Submitted June 8, 2005

What it changes

1 change to H.R. 2744

Adds a section
  1. Adds Sec. 7__. None of the funds made available in this Act may be used by the Secretary of Health and Human Services to keep in effect an exemption under section 505(i) of the Federal Food, Drug, and Cosmetic Act for a clinical trial that concerns a serious or life-threatening disease or condition and is not included in the registry of such trials under section 402(j) of the Public Health Service Act on page 83, line 19

    Adds a sectionPrinted page

    Inserted: Sec. 7__. None of the funds made available in this Act may be used by the Secretary of Health and Human Services to keep in effect an exemption under section 505(i) of the Federal Food, Drug, and Cosmetic Act for a clinical trial that concerns a serious or life-threatening disease or condition and is not included in the registry of such trials under section 402(j) of the Public Health Service Act.

    Inserted: Sec. 7__. None of the funds made available in this Act may be used by the Secretary of Health and Human Services to approve an application under section 505(b)(1) of the Federal Food, Drug, and Cosmetic Act that--

    Inserted: (1) is for a drug for a serious or life-threatening disease or condition; and

    Inserted: (2) is under subparagraph (A) of such section supported by a clinical trial that--

    Inserted: (A) has received an exemption under section 505(i) of such Act; and

    Inserted: (B) is not included in the registry of clinical trials under section 402(j) of the Public Health Service Act.

    Original wording

    Page 83, after line 19, insert the following sections:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed

Page 83, after line 19, insert the following sections:

Sec. 7__. None of the funds made available in this Act may be used by the Secretary of Health and Human Services to keep in effect an exemption under section 505(i) of the Federal Food, Drug, and Cosmetic Act for a clinical trial that concerns a serious or life-threatening disease or condition and is not included in the registry of such trials under section 402(j) of the Public Health Service Act.

Sec. 7__. None of the funds made available in this Act may be used by the Secretary of Health and Human Services to approve an application under section 505(b)(1) of the Federal Food, Drug, and Cosmetic Act that--

(1) is for a drug for a serious or life-threatening disease or condition; and

(2) is under subparagraph (A) of such section supported by a clinical trial that--

(A) has received an exemption under section 505(i) of such Act; and

(B) is not included in the registry of clinical trials under section 402(j) of the Public Health Service Act.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

3 earlier actions
Floor Latest Action

House amendment offered

June 8, 2005

View full timeline
Floor

House amendment offered

June 8, 2005

Not Used

House amendment offered/reported by : Amendment (A016) offered by Mr. Stupak.(consideration: CR H4263-4264; text: CR H4263)

June 8, 2005 • 6:09 PM

Floor

Amendment (A016) offered by Mr. Stupak. (consideration: CR H4263-4264; text: CR H4263)

June 8, 2005 • 6:09 PM

Floor

Mr. Bonilla raised a point of order against the Stupak amendment (A016). Mr. Bonilla stated that the amendment seeks to impose new duties and changes existing law. The Chair sustained the point of order.

June 8, 2005 • 6:14 PM